Skip to main content
Log in

Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin againstMycoplasma pneumoniae, Mycoplasma hominis andUreaplasma urealyticum

  • New Antimicrobial Agents
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The in vitro activity of three macrolides, azithromycin, clarithromycin and erythromycin and a new fluoroquinolone, lomefloxacin, against pathogenic mycoplasma (16 to 18 strains ofMycoplasma pneumoniae, 41 to 77 strains ofMycoplasma hominis, 65 to 104 strains ofUreaplasma urealyticum) was compared. The three macrolides were highly active againstMycoplasma pneumoniae. Clarithromycin was the most active macrolide againstUreaplasma urealyticum whereas azithromycin was somewhat more active than erythromycin againstMycoplasma hominis. Lomefloxacin was moderately active against all three mycoplasma species.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Waites KB, Cassell GH, Canup KC, Fernandes PB: In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. Antimicrobial Agents and Chemotherapy 1988, 32: 1500–1502.

    PubMed  Google Scholar 

  2. Rylander M, Hallander HO: In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide CP-62,993, againstMycoplasma pneumoniae, Mycoplasma hominis andUreaplasma urealyticum. Scandinavian Journal of Infectious Diseases 1988, Supplement 3: 12–17.

    Google Scholar 

  3. Bébéar C, Cantet P, Renaudin H, Quentin C: Activité comparée de la minocycline et de la doxycycline sur les mycoplasmes pathogènes pour l'homme. Pathologie Biologie 1985, 33: 577–580.

    PubMed  Google Scholar 

  4. Bébéar C, de Barbeyrac B, Bernet C, Renaudin H: Méthodes d'exploration des infections à mycoplasmes. Annales de Biologie Clinique 1989, 47: 415–420.

    PubMed  Google Scholar 

  5. Kenny GE, Hooton TM, Roberts MC, Cartwright FD, Hoyt J: Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrobial Agents and Chemotherapy 1989, 33: 103–107.

    PubMed  Google Scholar 

  6. Cassell GH, Waites KB, Pate MS, Canupp KC, Duffy LB: Comparative susceptibility ofMycoplasma pneumoniae to erythromycin, ciprofloxacin and lomefloxacin. Diagnostic Microbiology and Infectious Diseases 1989, 12: 433–436.

    Google Scholar 

  7. Renaudin H, Quentin C, de Barbeyrac B, Bébéar C: Activité in vitro de nouvelles quinolones sur les mycoplasmes pathogènes pour l'homme. Pathologie Biologie 1988, 36: 496–499.

    PubMed  Google Scholar 

  8. Bébéar C, Renaudin H, Maugein J, de Barbeyrac B, Clerc M: Pristinamycin and human mycoplasmas: in vitro activity compared with macrolides and lincosamides, in vivo efficacy inMycoplasma pneumoniae experimental infection. Zentralblatt für Bakteriologie 1990, Supplement 20: 77–82.

    Google Scholar 

  9. Benson CA, Segreti J, Beaudette FE, Hines DW, Goodman LJ, Kaplan RL, Trenholme GM: In vitro activity of A-56,268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. Antimicrobial Agents and Chemotherapy 1987, 31: 328–330.

    PubMed  Google Scholar 

  10. Jones BM, Kinghorn GR, Duerden BI: In vitro activity of azithromycin and erythromycin against organisms associated with bacterial vaginosis and chancroid. European Journal of Clinical Microbiology and Infectious Diseases 1988, 7: 551–553.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Renaudin, H., Bébéar, C. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin againstMycoplasma pneumoniae, Mycoplasma hominis andUreaplasma urealyticum . Eur. J. Clin. Microbiol. Infect. Dis. 9, 838–841 (1990). https://doi.org/10.1007/BF01967388

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967388

Keywords

Navigation